These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 16061657)
1. CD44 attenuates metastatic invasion during breast cancer progression. Lopez JI; Camenisch TD; Stevens MV; Sands BJ; McDonald J; Schroeder JA Cancer Res; 2005 Aug; 65(15):6755-63. PubMed ID: 16061657 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. Yu Q; Toole BP; Stamenkovic I J Exp Med; 1997 Dec; 186(12):1985-96. PubMed ID: 9396767 [TBL] [Abstract][Full Text] [Related]
3. Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. Tzircotis G; Thorne RF; Isacke CM J Cell Sci; 2005 Nov; 118(Pt 21):5119-28. PubMed ID: 16234326 [TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors. Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. Bourguignon LY; Singleton PA; Zhu H; Diedrich F J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184 [TBL] [Abstract][Full Text] [Related]
6. Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway. Sarkar A; Chanda A; Regmi SC; Karve K; Deng L; Jay GD; Jirik FR; Schmidt TA; Bonni S PLoS One; 2019; 14(7):e0219697. PubMed ID: 31361756 [TBL] [Abstract][Full Text] [Related]
7. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272 [TBL] [Abstract][Full Text] [Related]
8. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639 [TBL] [Abstract][Full Text] [Related]
9. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Afify A; Purnell P; Nguyen L Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378 [TBL] [Abstract][Full Text] [Related]
10. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Herrera-Gayol A; Jothy S Exp Mol Pathol; 1999 Apr; 66(1):99-108. PubMed ID: 10331969 [TBL] [Abstract][Full Text] [Related]
11. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545 [TBL] [Abstract][Full Text] [Related]
12. CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2. Chang G; Wang J; Zhang H; Zhang Y; Wang C; Xu H; Zhang H; Lin Y; Ma L; Li Q; Pang T Br J Cancer; 2014 Feb; 110(4):916-27. PubMed ID: 24434427 [TBL] [Abstract][Full Text] [Related]
13. Role of CD44 and hyaluronan in neutrophil recruitment. Khan AI; Kerfoot SM; Heit B; Liu L; Andonegui G; Ruffell B; Johnson P; Kubes P J Immunol; 2004 Dec; 173(12):7594-601. PubMed ID: 15585887 [TBL] [Abstract][Full Text] [Related]
14. HAS2 and CD44 in breast tumorigenesis. Heldin P; Basu K; Kozlova I; Porsch H Adv Cancer Res; 2014; 123():211-29. PubMed ID: 25081531 [TBL] [Abstract][Full Text] [Related]
15. Human breast-cancer metastasis formation in a nude-mouse model: studies of hyaluronidase, hyaluronan and hyaluronan-binding sites in metastatic cells. Victor R; Chauzy C; Girard N; Gioanni J; d'Anjou J; Stora De Novion H; Delpech B Int J Cancer; 1999 Jul; 82(1):77-83. PubMed ID: 10360824 [TBL] [Abstract][Full Text] [Related]
16. In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Ouhtit A; Abd Elmageed ZY; Abdraboh ME; Lioe TF; Raj MH Am J Pathol; 2007 Dec; 171(6):2033-9. PubMed ID: 17991717 [TBL] [Abstract][Full Text] [Related]
17. The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue. Knudson W Front Biosci; 1998 Jul; 3():d604-15. PubMed ID: 9634543 [TBL] [Abstract][Full Text] [Related]
18. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo. Chen J; He H; Deng C; Yin L; Zhong Z Int J Pharm; 2019 Apr; 560():57-64. PubMed ID: 30699364 [TBL] [Abstract][Full Text] [Related]
19. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
20. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. Ghatak S; Hascall VC; Markwald RR; Misra S J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]